This website uses cookies to improve your experience. Learn more about cookies and how to manage them.

British Pharmacological Society in the news


President David Webb responds to review of evidence on the efficacy and safety of statins in the Lancet

09 Sep 2016

Professor David Webb, President of the British Pharmacological Society, provided expert comment on a review of evidence on efficacy and safety of statins, as published in the Lancet.

BJCP article: Colour-graded pictogram label to reduce medicine-related traffic crashes found ineffective

02 Sep 2016

A new study, published in the British Journal of Clinical Pharmacology, questions the effectiveness of using pictogram message on the labels of anxiety and sleep medications that interfere with driving – an approach this is currently implemented across France.

BBC Radio 4 - Personalised medicine: Dose by design

23 Aug 2016

The Society's Vice President – Clinical, Prof Sir Munir Pirmohamed, was recently on a BBC Radio 4 programme 'Personalised medicine: Dose by dose' discussing pharmacogenetics.

BJCP article: Zinc lozenges help most patients recover earlier from the common cold

21 Jul 2016

Zinc acetate lozenges may reduce the duration of the common cold by nearly 3 days, according to a recent analysis in the British Journal of Clinical Pharmacology.

BJCP article: Many elderly people are receiving and using prescription medications inappropriately

19 Jul 2016

A new study from Belgium indicates that the majority of community-dwelling elderly adults are taking prescription medications inappropriately. The study, which is published in the British Journal of Clinical Pharmacology, also found a link between underuse—not taking essential medications—and an increased risk of dying or needing to be hospitalized.

BJCP article: Most people don't sleep any worse when taking medicines with sleep disturbance warnings

14 Jun 2016

Medicines that carry warnings about sleep disturbances do not seem to contribute to the amount of sleep disturbances in the general population, according to new ‘real world’ research. The findings, which are published in the British Journal of Clinical Pharmacology suggest that investigators may need to provide more careful reporting of side effects in clinical trials, and emphasizes the value of research into the safety of medicines once they are being taken by the general population.

BJCP editorial: Organised crime against the academic peer review system

07 Jun 2016

Adam Cohen, Editor-in-Chief of the British Journal of Clinical Pharmacology (BJCP), published an editorial titled 'Organised crime against the academic peer review system' in the latest issue of BJCP following a retraction of an article.

Cheltenham Science Festival 2016 coverage

07 Jun 2016

Read about coverage of the Society's public event at the Times Cheltenham Science Festival.  

Pharmacologists speak to the Independent about the Psychoactive Substances Act

26 May 2016

Pharmacologists spoke to Adam Lusher of the Independent to discuss the enforcement of the Psychoactive Substances Act and accompanying forensic strategy in the UK.

Waste not, want not: How not wasting medicines could benefit patient health and save the NHS millions

05 Apr 2016

A public event organised by the British Pharmacological Society explored the impact of wasted medicines on patient health – and the financial health of the NHS – as part of the Edinburgh International Science Festival. The event provided a forum for patients and healthcare professionals to consider the reasons why medicines are wasted and explore potential solutions.

Member response to GSK's decision to adopt approach to intellectual property the reflects a country's economic maturity

31 Mar 2016

Our Honorary Fellow responded to GlaxoSmithKline's decision to adopt an approach to intellectual property that reflects a country’s economic maturity